The National Cancer Data Base report on endometrial carcinoma in African-American women

✍ Scribed by Michael L. Hicks; Jerri Linn Phillips; Groesbeck Parham; Nancy Andrews; Walter B. Jones; Hugh M. Shingleton; Herman R. Menck

• Publisher: John Wiley and Sons
• Year: 1998
• Tongue: English
• Weight: 127 KB
• Volume: 83
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/(sici)1097-0142(19981215)83:12<2629::aid-cncr30>3.0.co;2-2

✦ Synopsis

BACKGROUND.

Although the incidence of uterine carcinoma is lower among African-American women compared with white women, the mortality rates are higher for African-American patients. This report is part of an ongoing series on gynecologic malignancies in African-American women.

METHODS.

Hospital registry reports collected by the National Cancer Data Base were used to describe some of the differences in case presentation and management characteristics of endometrial carcinoma in these two groups. The cases represented 52,307 Non-Hispanic white and 3226 African-American women diagnosed with primary carcinoma of the endometrium between 1988 -1994.

RESULTS.

More African-American patients were diagnosed with less favorable histologies than white patients, at more advanced stages of disease, and with less tumor differentiation. Income had no effect on stage or grade. African-American patients were treated less often for their tumor at every stage of diagnosis compared with white women. Income generally had no effect on whether treatment was provided, but limited income was associated with a lack of treatment in African-American patients with American Joint Committee on Cancer Stage IV tumors. African-American women were less frequently treated surgically and, among surgically treated patients at advanced stages of disease, they received adjuvant radiotherapy less often and chemotherapy more often than white patients. Five-year survival was poorer for African-American women, even for patients with the more favorable Stage I adenocarcinoma who were treated surgically.

CONCLUSIONS.

All patients, regardless of race, should be treated appropriately as dictated by medical and prognostic factors and not by race. Although no screening